Need to identify and develop digital strategies for manufacturing? DPMM is for you

9 January 2024
Information Technology
James Colley
Phorum Director

In 2016, the BioPhorum IT (BPIT) collaboration group created the original Digital Plant Maturity Model (DPMM) and high-level Assessment Tool to help you conduct single-plant and manufacturing-network assessments with a high degree of consistency. It described five maturity levels ranging from manual paper-based to the fully automated ‘adaptive’ plant of the future.

Driven by the need to reflect progress made in available technologies and new business models, and lift the maturity levels as more factories adopt Industry 4.0 principles, we have updated and refreshed the DPMM Assessment Tool and associated guidance.

The updated DPMM Assessment Tool is a structured and straightforward way to assess the digital maturity of your plants and set a target maturity level aligned with your company’s digital strategy. Companies can easily adopt the tool to support benchmarking and investment decisions. Adopting the DPMM 3.0 and the Assessment Tool can increase your digital maturity and give you the flexibility to carry out a quick plant assessment at

one site or a more detailed assessment across multiple plants.

Version 3.0 has an increased focus on quality with two new dimensions: ‘quality control’ and ‘Quality Management Systems’. ‘Process development’ is a new dimension emphasizing technology transfer and the previous ‘IT Security and Operations’ dimension has been revised. ‘Cybersecurity’ now focuses on applying proper security controls to protect the availability, integrity, and confidentiality of systems that operate up to an adaptive digital plant level.

“If you are looking for a comprehensive model that gives you a clear digital picture of your network, the DPMM is the one to adopt,” said Yves Berthouzoz, Head of IT Biotech Operations and CMC Development at Merck. “It is simple, clear, and provides a view across all your sites. The five levels allow you to not only understand your current digital maturity but also build your digital strategy and ask for support from your sponsors. Additionally, if you need help, it gives you the right insight on how to progress in your digital journey.”

Two new papers support the updated Assessment Tool.

DPMM 3.0 addendum to the DPMM v1

This explains the development of the DPMM 3.0 and the Assessment Tool and reflects how industry has changed since the first DPMM. For example, what a ‘good’ connected or predictive plant looked like five years ago has changed because industry and technology have evolved. The DPMM 3.0 has been developed to cover what is possible today and define a vision that is beyond the capabilities of current manufacturing and IT technologies.

A best practice guide to using the BioPhorum Digital Plant Maturity Model and Assessment Tool v3.0

This sets out the intended use of the DPMM and Assessment Tool to support digital maturity assessments, identify capabilities to develop, create strategic plans and roadmaps, influence technology suppliers, and develop human resource competency and development frameworks.

We demonstrate the need for using such a tool for plant assessments in manufacturing and detail the refreshed five levels of maturity to identify the commonalities within the industry. It describes two approaches to using the assessment tool – quick and detailed – while sharing learning and indicating future direction.

In developing the DPMM, we have formulated a set of transformational milestones for bringing disruption and innovation to an inherently risk-averse and highly regulated environment. Biopharmaceutical manufacturers and their technology suppliers can now chart their progress using these milestones. The alignment between the DPMM and the BioPhorum Biomanufacturing Technology Roadmap will help ensure that your digital roadmap is aligned with transformative advances in how medicines are made.

In defining today’s needs for advanced-level adaptive plants that are beyond current technologies, the DPMM 3.0 provides a robust platform to identify and develop digital strategies for manufacturing to ensure a reliable supply of transformative medicines to patients worldwide. For more information, download the tool and supporting papers here or email with your feedback.

Digital arrow, blue
Where to start with your biomanufacturing digital transformation
Circles Infront Of Bridge
How to bridge the data integration gap between sponsors and contract organizations
Are you ready for a cyberattack on your OT systems?
BioPhorum’s vision for standardizing the traceability of CGTs
Digital Toolkit
How to make a success of your smart maintenance projects

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Investigation Digital Workstreams
Peer to peer practical guidance on remote inspections and audits
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
BioPhorum roundals on sugical gloves
A visionary strategic framework for future patient-centric outbound biopharmaceutical supply chains
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
Lightbulb And Icons On Colourful Background
BioPhorum environmental sustainability roadmap 2022
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing